Description: NIOX Group Plc, a diagnostics and management company, provides point-of-care fractional exhaled nitric oxide (FeNo) diagnosis and management products worldwide. Its products include NIOX VERO, a portable system for the non-invasive measurement of nitric oxide in human breath. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Home Page: investors.niox.com
NIOX Technical Analysis
Hayakawa Building
Oxford,
OX4 4GB
United Kingdom
Phone:
44 18 6540 5560
Officers
| Name | Title |
|---|---|
| Mr. Ian Roy Johnson | Exec. Chairman |
| Mr. Michael Roy David Roller A.C.A., ACA, BA (Hons) | CFO & Director |
| Mr. Jonathan Emms | COO & Exec. Director |
| Ms. Nina Kataria | Sr. VP Global HR |
| Mr. Tom Scaccia | Sr. VP of Americas & Research Bus. |
| Ms. Sarah Duncan | Company Sec. |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 46.0829 |
|---|---|
| Trailing PE: | 12.391 |
| Price-to-Book MRQ: | 2.118 |
| Price-to-Sales TTM: | 5.5215 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 111 |